Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
4.490
-0.110 (-2.39%)
May 13, 2025, 4:00 PM - Market closed
Amylyx Pharmaceuticals Employees
Amylyx Pharmaceuticals had 123 employees as of December 31, 2024. The number of employees decreased by 261 or -67.97% compared to the previous year.
Employees
123
Change (1Y)
-261
Growth (1Y)
-67.97%
Revenue / Employee
n/a
Profits / Employee
-$1,779,325
Market Cap
397.83M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 123 | -261 | -67.97% |
Dec 31, 2023 | 384 | 122 | 46.56% |
Dec 31, 2022 | 262 | 57 | 27.80% |
Dec 31, 2021 | 205 | 171 | 502.94% |
Dec 31, 2020 | 34 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AMLX News
- 21 hours ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Investors to Reach Out - Accesswire
- 2 days ago - Amylyx Pharmaceuticals Announces Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome - Business Wire
- 2 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Reach Out - Accesswire
- 3 days ago - Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Stockholders to Connect - Accesswire
- 6 days ago - Amylyx Pharmaceuticals Reports First Quarter 2025 Financial Results - Business Wire
- 6 days ago - Amylyx Pharmaceuticals to Participate in Upcoming May Investor Conferences - Business Wire
- 7 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Shareholders to Connect - Accesswire